Hepion Pharmaceuticals, Inc.

HEPA

Hepion Pharmaceuticals, Inc.

HEPA

Insider Sentiment (TTM):

Last Purchase:2026-04-21Last Sale:-Shares Purchased (TTM):10,000,000Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:1Shares Outstanding:11,620,317Institutional Ownership Pct.:0.00%

Earnings Market Reaction:

Filing Date:2026-08-13Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Series A Preferred Stock	-	-	-	-	-	-	-	-	-	0	0	0
Assets
Assets Current
Cash	2	3	2	2	3	5	0	1	2	13	15	19
Prepaid Expense And Other Assets Current	-	-	-	-	-	-	-	-	3	2	-	2
Prepaid Expense Current	0	0	1	1	2	2	1	1	-	-	3	-
Assets Current	2	3	3	4	5	6	2	4	5	15	17	21
Property Plant And Equipment Net	-	-	-	-	-	-	-	-	-	0	0	0
Assets	2	3	3	4	5	6	2	4	6	16	18	25
Indefinite Lived Intangible Assets Excluding Goodw…	-	-	-	-	-	-	-	-	-	-	0	3
Liabilities And Stockhold…
Operating Lease Right Of Use Asset	-	-	0	-	-	-	-	0	0	0	0	0
Other Assets Noncurrent	-	-	-	-	-	-	-	0	-	-	0	-
Liabilities Current
Other Assets	-	-	-	-	-	-	-	-	0	0	0	0
Accounts Payable Current	0	0	0	0	0	0	0	0	0	1	2	3
Accrued Liabilities Current	0	0	0	0	0	0	0	0	0	1	2	3
Notes Payable Current	-	-	0	0	0	1	3	2	-	-	-	-
Other Liabilities Current	-	0	-	-	-	-	-	-	-	-	-	-
Liabilities Current	0	1	0	0	1	1	3	3	1	3	5	6
Business Combination Contingent Consideration Liab…	-	-	-	-	-	-	-	-	-	1	2	2
Operating Lease Liability Noncurrent	-	-	-	-	-	-	-	-	-	0	0	0
Derivative Liabilities Noncurrent	0	0	0	0	0	1	0	1	1	5	4	-
Deferred Income Tax Liabilities Net	-	-	-	-	-	-	-	-	-	-	0	0
Liabilities	1	1	0	0	1	2	3	4	2	8	11	9
Stockholders Equity
Operating Lease Liability Current	-	-	-	-	-	-	-	0	0	0	0	0
Business Combination Contingent Consideration Liab…	-	-	-	-	-	-	-	-	-	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	248	247	247	247	247	246	234	234	233	233	230	228
Accumulated Other Comprehensive Income Loss Net Of…	0	0	0	0	0	0	0	-0	-0	0	-0	-0
Retained Earnings Accumulated Deficit	-248	-247	-246	-245	-245	-244	-238	-236	-231	-227	-225	-214
Stockholders Equity	1	2	3	3	4	4	-2	0	4	8	7	16
Liabilities And Stockholders Equity	2	3	3	4	5	6	2	4	6	16	18	25
Series C Preferred Stock	-	-	-	-	-	-	-	-	-	0	0	0
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	120	120	120	120	120	120	120	120	120	120	120	120
Common Stock Shares Issued	29	12	12	12	12	10	0	0	0	0	0	0
Shares Outstanding	29	12	12	12	12	10	0	0	0	0	0	0

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-15.79%	-11.58%	-51.58%	-	-	-	-	-	-	-	-	-
2025	-27.84%	-38.14%	-34.02%	30.00%	15.00%	11.67%	20.90%	-10.45%	-47.76%	-8.33%	5.00%	10.00%
2024	-5.21%	-8.55%	-48.72%	22.71%	10.17%	10.17%	-6.77%	-4.21%	-72.93%	-30.49%	-86.59%	-82.93%
2023	-	-	-	-6.24%	-33.24%	-38.32%	26.35%	-12.70%	-51.75%	-38.24%	-46.08%	-50.98%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	3.91	3.68	10.25	10.77	7.60	6.75	0.51	1.30	5.62	5.99	3.31	3.32
Quick Ratio	3.31	3.54	6.11	6.68	4.93	4.90	0.13	0.77	2.17	5.09	2.80	3.01
Working Capital	1.43M	1.97M	2.77M	3.39M	3.91M	5.38M	-1.53M	814.33K	4.51M	12.86M	12.20M	14.87M
Leverage & Debt
Debt to Equity	0.51	0.46	0.15	0.13	0.19	0.62	-1.87	10.14	0.69	1.13	1.49	0.55
Interest Coverage TTM	-108.29	-132.97	-82.66	-5.56	-6.57	-11.30	-14.37	-53.79	-592.38	-3,517.33	-5,118.64	-4,998.14
Debt Ratio	0.34	0.31	0.13	0.11	0.16	0.38	2.15	1.11	0.41	0.53	0.60	0.35
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-0.20	-0.26	-0.88	-0.79	-1.20	-5.80	-107.35	-168.96	-244.57	-379.69	-616.07	-622.87
Free Cash Flow Per Share TTM	-0.20	-0.14	-0.35	-0.26	-0.45	-5.54	-148.23	-193.97	-299.93	-357.92	-515.11	-478.34
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	-76.49%	-81.86%	-37.25%	-59.62%	-52.19%	-57.31%	-73.04%	-52.52%	-38.12%	-25.45%	7.92%	5.99%
EPS Growth (1Y)	-83.55%	-95.57%	-99.18%	-99.53%	-99.51%	-98.47%	-82.58%	-72.87%	-59.17%	-43.98%	3.58%	5.25%
Valuation Metrics
P/E TTM	-0.35	-0.22	-0.07	-0.06	-0.07	-0.07	-0.22	-0.20	-0.21	-0.33	-0.26	-0.40
P/B TTM	0.86	0.36	0.21	0.17	0.24	0.31	-1.55	11.07	1.66	1.68	1.77	1.19
Market Cap	1.10M	662.36K	564.56K	581.02K	906.25K	1.22M	2.89M	4.50M	5.92M	12.63M	12.87M	19.15M
Enterprise Value	-527.47K	-1.94M	-1.21M	-1.53M	-1.65M	-2.84M	5.38M	5.11M	3.80M	-474.98K	-1.92M	-131.02K
Calculated Values
Free Cash Flow TTM	-3.29M	-1.58M	-3.27M	-2.97M	-5.05M	-15.72M	-18.22M	-26.07M	-34.79M	-36.31M	-40.91M	-36.72M
Net Debt	-1.63M	-2.60M	-1.77M	-2.11M	-2.55M	-4.06M	2.49M	608.65K	-2.12M	-13.11M	-14.79M	-19.28M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-04-21Purchase

Owner: Lopriore, Vincent S

Title: Executive Chairman

Shares: 6,250,000

Price/Share: $0.04

Value: $250,000.00

Shares Owned: 6,250,000

Relationship: Director,Officer,TenPercentOwner

Ownership: Indirect

2026-04-21Purchase

Owner: Purcell, Michael J.

Title: -

Shares: 1,250,000

Price/Share: $0.04

Value: $50,000.00

Shares Owned: 1,250,000

Relationship: Director

Ownership: Direct

2026-04-21Purchase

Owner: Stetz, Gary S.

Title: Interim CEO

Shares: 1,250,000

Price/Share: $0.04

Value: $50,000.00

Shares Owned: 1,250,000

Relationship: Director,Officer

Ownership: Indirect

2026-04-21Purchase

Owner: Appajosyula, Sireesh

Title: -

Shares: 1,250,000

Price/Share: $0.04

Value: $50,000.00

Shares Owned: 1,250,000

Relationship: Director

Ownership: Direct

2023-11-27Purchase

Owner: Wijngaard, Peter

Title: -

Shares: 2,500

Price/Share: $3.05

Value: $7,625.00

Shares Owned: 9,501

Relationship: Director

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-04-21	Lopriore, Vincent S	Director,Officer,TenPercentOwner	Executive Chairman	Indirect	Purchase	6,250,000	0.04	$250,000.00	6,250,000	4
2026-04-21	Purcell, Michael J.	Director	-	Direct	Purchase	1,250,000	0.04	$50,000.00	1,250,000	4
2026-04-21	Stetz, Gary S.	Director,Officer	Interim CEO	Indirect	Purchase	1,250,000	0.04	$50,000.00	1,250,000	4
2026-04-21	Appajosyula, Sireesh	Director	-	Direct	Purchase	1,250,000	0.04	$50,000.00	1,250,000	4
2023-11-27	Wijngaard, Peter	Director	-	Direct	Purchase	2,500	3.05	$7,625.00	9,501	4
2023-09-19	Wijngaard, Peter	Director	-	Direct	Purchase	1,000	5.64	$5,640.00	4,501	4
2023-09-18	Foster, Robert T	Director,Officer	CEO and Director	Direct	Purchase	1,600	5.60	$8,960.00	50,470	4
2023-09-15	Foster, Robert T	Director,Officer	CEO,CSO and Director	Direct	Purchase	1,600	5.40	$8,640.00	48,870	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

0.00%

Inst. Shares: 1

Shares Outstanding: 11,620,317

2025-12-31

0.00%

Inst. Shares: 1

Shares Outstanding: 9,409,375

2025-09-30

0.00%

Inst. Shares: 1

Shares Outstanding: 11,620,317

2025-06-30

0.15%

Inst. Shares: 17,362

Shares Outstanding: 11,328,122

2025-03-31

33.84%

Inst. Shares: 959,991

Shares Outstanding: 2,836,700

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	1	11,620,317	0.00%
2025-12-31	1	9,409,375	0.00%
2025-09-30	1	11,620,317	0.00%
2025-06-30	17,362	11,328,122	0.15%
2025-03-31	959,991	2,836,700	33.84%
2024-12-31	498,814	122,894	-
2024-09-30	545,356	134,379	-
2024-06-30	841,676	115,983	-
2024-03-31	711,630	101,450	-
2023-12-31	734,182	79,416	-
2023-09-30	801,828	76,766	-
2023-06-30	503,529	76,530	-
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Hepion Pharmaceuticals, Inc. (HEPA) — SEC Financial Statements & Analysis

Hepion Pharmaceuticals, Inc. (HEPA) is a pharmaceutical preparations company, incorporated in DE. Hepion Pharmaceuticals, Inc. trades on OTC as: HEPA, CTRVP. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Hepion Pharmaceuticals, Inc. reported a Debt-to-Equity ratio of 0.51x, a Price-to-Book (P/B) ratio of 0.86x (TTM), at a market cap of $1.10M. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: 0.51x
P/B TTM: 0.86x
Market Cap: $1.10M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Hepion Pharmaceuticals, Inc. in?

Hepion Pharmaceuticals, Inc. (HEPA) operates in the Pharmaceutical Preparations industry.

What is HEPA's market cap?

Hepion Pharmaceuticals, Inc. (HEPA) has a market capitalization of $1.10M as of 2026-06-30.

What exchange does HEPA trade on?

Hepion Pharmaceuticals, Inc. (HEPA) trades on the OTC.

Where is Hepion Pharmaceuticals, Inc. incorporated?

Hepion Pharmaceuticals, Inc. is incorporated in DE.